Register

Registration

Note : After Answered of Questionnaires / Survey Please Close it.
.

Coral Laboratories Ltd . Small Cap

BSE: 524506 | NSE:
Pharmaceuticals
Live
15/04/2021 1:30:00 PM
334.45 -0.80   (-0.24%)
BSE: price shown with 5 mins delayed.
Prev. Close 335.25
Open Price 343.90
Volume Traded 1135.00

Fundamentals

Mar'11 Mar'12 Mar'13 Mar'14 Mar'15 Mar'16 Mar'17 Mar'18 Mar'19 Mar'20
Ajusted EPS(Rs.)
Net Sales (Rs. Cr.)
Adjusted Net Profit
Book Value/ Share(Rs.)
Cash Flow
Debt to Cash Flow from Operations
RONW
ROCE %
Net Operating Profit Margin %
Net Profit Margin %
Debt / Equity
Dividend Yield %
Mar'11 Mar'12 Mar'13 Mar'14 Mar'15 Mar'16 Mar'17 Mar'18 Mar'19 Mar'20
Ajusted EPS(Rs.) 11.4 15.57 16.63 21.68 26.28 34.09 45.61 34.84 28.6 19.96
Net Sales (Rs. Cr.) 32.7 39.96 41.51 50.8 59.42 77.02 95.47 92.47 91.08 70.58
Adjusted Net Profit 4.16 5.64 6.03 7.87 9.57 12.39 16.54 12.45 10.22 7.12
Book Value/ Share(Rs.) 92.75 106.76 121.89 141.57 165.35 196.44 305.54 325.63 318.45 323.77
Cash Flow 0.13 3.08 0.99 1.85 -0.12 2.27 1.44 -2.36 1.17 -1.85
Debt to Cash Flow from Operations 0.05 0.00 5.20 0.19 3.70 0.07 0.20 0.13 -1.64 -1.53
RONW 0.00 0.00 14.76 16.73 17.46 19.19 18.18 11.04 8.88 6.22
ROCE % 16.37 19.90 18.53 21.11 22.10 26.79 27.13 15.85 13.39 7.83
Net Operating Profit Margin % 19.57 20.50 20.68 21.43 24.20 24.34 27.36 21.21 19.12 15.76
Net Profit Margin % 12.51 13.87 14.11 15.05 15.67 15.78 17.07 13.46 11.22 10.10
Debt / Equity 0.05 0.00 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.03
Dividend Yield % 1.90 2.01 2.48 2.37 1.07 0.66 0.86 0.62 1.51 0.00

Year on Year Growth Rate (%)

Ajusted EPS Sales Adjusted Net Profit

Latest Financials

Standalone Consolidated
TTM EPS (Rs) 42.85
TTM Sales (Rs. Cr.) 89.3
BVPS (Rs.) 363.89
Reserves (Rs. Cr.) 126.34
P/BV 0.92
PE 7.82
From the Market
52 Week High / Low (Rs) 443.3/126.5
All Time High / Low (Rs) 1190/7.25
Volume Traded 1135
Market Cap (Rs. Cr.) 119.68
Equity (Rs. Cr.) 3.57
Face Value (Rs) 10
Industry PE 0

Quarterly Results

Mar'2020 Jun'2020 Sep'2020 Dec'2020
Net Sales (Cr) 20.55 22.28 18.13 28.34
Adjusted EPS (Rs) 9.78 14.76 5.38 12.97
Net Profit Margin % 16.98 23.65 10.59 16.34
Mar'2020 Jun'2020 Sep'2020 Dec'2020
Net Sales (Cr)
Adjusted EPS (Rs)
Net Profit Margin %

Quarterly Growth Rate (%)

Ajusted EPS Sales Net Profit Margin

Peers Data

Name Current Price(Rs) Market Cap. (Rs. cr.) Net Profit(Rs. cr.) Sales Growth(%)

Technical

Sector

22585.27 185.45   (0.83%)

Index

48322.50 -221.56   (-0.46%)
9 Days Avg
Span A Span B 52 Week TenKan-Sen Kijun-Sen ChiKou-Sen
9 Days Avg

Score

Kindly subscribe to get access

Research Analytical

Kindly subscribe to get access

News

About Company

Coral Laboratories Limited has been promoted by Navin B Doshi of the DWD group. The Company is spearheaded by Kishor R Mehta as Executive Director. CLL produces various pharmaceutical formulations. To Manufacture pharmaceutical formulations like tablets,capsules the company went into public issue in March 94 at a total cost of Rs.2.5 crores. The project has been completed successfully CLL plans to expand its activities in the present premises by foraying into the sophisticated FFS (form fill and seal) technology for injections. The machinery for the said technology will be imported. The Coral group is also diversifying into housing construction and financial services for which a new company, Coral India Finance and Housing, will be incorporated.During the year 1999-2000, the company has received ISO-9002 Certification.